Synonyms:
Status: Phase 3
Entry Type: Small molecule
Molecule Category: Parent
UNII: AB5K82X98Y

Structure

InChI Key IHOVFYSQUDPMCN-DBEBIPAYSA-N
Smile O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
InChI
InChI=1S/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29-,30+,31-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C32H31F2N3O2
Molecular Weight 527.62
AlogP 5.21
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 6.0
Polar Surface Area 48.83
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 39.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR P-glycoprotein 1 inhibitor PubMed PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Transporter Primary active transporter ATP-binding cassette ABCB subfamily
- 59 - - 40-58

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia 1 D007938 ClinicalTrials

Related Entries

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 167354-41-8
ChEMBL CHEMBL444172
DrugBank DB06191
EPA CompTox DTXSID9057894
FDA SRS AB5K82X98Y
PDB ZQU
SureChEMBL SCHEMBL12432743
ZINC ZINC000100029945